NASDAQ · CERS
Cerus Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CERS: Nov 02, 2026
Cerus Corporation Common Stock is expected to report earnings on 11/02/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.01. The reported EPS for the same quarter last year was $0.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Dec 2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · MarketBeat · Zacks · Fintel- BNK Invest · Jul 31, 12:03 PM EDTFriday's ETF Movers: GXUS, ARKKIn trading on Friday, the Goldman Sachs MarketBeta Total International Equity ETF is outperforming other ETFs, up about 2.9% on the day. Components of that ETF showing particular strength include shares of Vista Energy, up about 1.2% and shares of Grab Holdings, up about 1.2% o
- MarketBeat · Jul 30, 6:04 PM EDTCerus Q2 Earnings Call HighlightsCerus (NASDAQ:CERS) reported second-quarter product revenue growth of 10% year over year and raised the low end of its 2026 product revenue outlook, citing demand for its INTERCEPT blood-safety products in North America and overseas. Product revenue totaled $57.4 million for the
- Zacks · Jun 4, 9:40 AM EDTIs BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year?Here is how BrightSpring Health Services, Inc. (BTSG) and Cerus (CERS) have performed compared to their sector so far this year.
- Fintel · May 1, 7:21 PM EDTBTIG Upgrades Cerus (CERS)Fintel reports that on May 1, 2026, BTIG upgraded their outlook for Cerus (NasdaqGM:CERS) from Neutral to Buy. Analyst Price Forecast Suggests 87.50% Upside
- The Motley Fool · Apr 30, 7:26 PM EDTCerus (CERS) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- The Motley Fool · Mar 2, 5:49 PM ESTCerus (CERS) Q4 2025 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Jan 13, 10:20 PM ESTAfter-Hours Biotech Rally: SXTC, RPID, TGTX Lead Gains On Revenue Updates, And FDA Milestones(RTTNews) – Several biotechnology and pharmaceutical names posted notable gains in Tuesday's after-hours trading session, driven by corporate updates and investor enthusiasm around clinical and financial milestones.
- RTTNews · Dec 10, 11:49 PM ESTAfter-Hours Gainers: Biotech Stocks Climb On Data Anticipation And Momentum Buying(RTTNews) – U.S. after-hours trading on Wednesday saw a wave of gains across several small-cap and micro-cap biotech names, with a mix of catalyst-driven moves and sentiment-based rebounds. While a few companies advanced on upcoming clinical milestones or recent data presentation
- Validea · Sep 20, 6:24 AM EDTValidea James P. O'Shaughnessy Strategy Daily Upgrade Report – 9/20/2025The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative st
- Validea · Jul 3, 5:19 AM EDTValidea James P. O'Shaughnessy Strategy Daily Upgrade Report – 7/3/2025The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative st
- Zacks · May 1, 5:05 PM EDTCerus (CERS) Reports Q1 Loss, Tops Revenue EstimatesCerus (CERS) delivered earnings and revenue surprises of 20% and 2.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
- Quiver Quantitative · Apr 16, 7:16 PM EDTLobbying Update: $40,000 of CERUS CORPORATION lobbying was just disclosed$40,000 of CERUS CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Cerus Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.